Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 3Phase 2 2Phase 4 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 76Thoracic 6Gastrointestinal 5Breast 3Head & Neck 2Gynecologic 2Sarcoma 1Other hematologic neoplasm 1Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 8Anemia, Refractory, with Excess of Blasts 6Myelodysplastic Syndromes 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Primary Myelofibrosis 3Leukemia, Myelomonocytic, Chronic 3Thrombocytopenia 2Neoplasms 2Lymphoma 2Leukemia, Biphenotypic, Acute 2Congenital Abnormalities 2Blast Crisis 2Anemia, Refractory 2Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Urologic Neoplasms 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Sezary Syndrome 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1

Interventions

Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Prostatic Neoplasms × Classical hematology × Clear all
NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

University of Aarhus

Phase 2/3 Terminated
140 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡